1. Home
  2. LEGN vs WCC Comparison

LEGN vs WCC Comparison

Compare LEGN & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • WCC
  • Stock Information
  • Founded
  • LEGN 2014
  • WCC 1922
  • Country
  • LEGN United States
  • WCC United States
  • Employees
  • LEGN N/A
  • WCC N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • WCC Telecommunications Equipment
  • Sector
  • LEGN Health Care
  • WCC Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • WCC Nasdaq
  • Market Cap
  • LEGN 5.4B
  • WCC 8.1B
  • IPO Year
  • LEGN 2020
  • WCC 1999
  • Fundamental
  • Price
  • LEGN $28.95
  • WCC $167.86
  • Analyst Decision
  • LEGN Strong Buy
  • WCC Buy
  • Analyst Count
  • LEGN 12
  • WCC 8
  • Target Price
  • LEGN $77.09
  • WCC $212.00
  • AVG Volume (30 Days)
  • LEGN 1.9M
  • WCC 635.2K
  • Earning Date
  • LEGN 05-13-2025
  • WCC 05-01-2025
  • Dividend Yield
  • LEGN N/A
  • WCC 1.08%
  • EPS Growth
  • LEGN N/A
  • WCC 10.34
  • EPS
  • LEGN N/A
  • WCC 13.26
  • Revenue
  • LEGN $728,303,000.00
  • WCC $21,812,500,000.00
  • Revenue This Year
  • LEGN $64.21
  • WCC $4.13
  • Revenue Next Year
  • LEGN $53.69
  • WCC $4.27
  • P/E Ratio
  • LEGN N/A
  • WCC $12.66
  • Revenue Growth
  • LEGN 112.46
  • WCC N/A
  • 52 Week Low
  • LEGN $27.34
  • WCC $125.21
  • 52 Week High
  • LEGN $60.87
  • WCC $216.17
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.56
  • WCC 52.67
  • Support Level
  • LEGN $28.13
  • WCC $161.70
  • Resistance Level
  • LEGN $29.31
  • WCC $175.36
  • Average True Range (ATR)
  • LEGN 1.63
  • WCC 4.00
  • MACD
  • LEGN 0.03
  • WCC -0.29
  • Stochastic Oscillator
  • LEGN 27.01
  • WCC 41.51

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About WCC WESCO International Inc.

Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.

Share on Social Networks: